Switzerland and Sweden are two of the most important global players in the creation of solution-driven products and techniques in the life science sector.
To ensure that both Swiss and Swedish academia and SMEs continue to remain at the forefront on the global medical & bio technology market, they need to apply state-of-the art scientific findings. The road from laboratory to market is bumpy and many researchers from academia and SMEs find it difficult to cope with limited financial capabilities.
Switzerland and Sweden have traditionally well-established co-operations within the field of medical and biotechnology. The sectors are also defined as strategic in both countries. Due to this, medical and biotechnology have been chosen as two of the areas for promotion of Swiss-Swedish R&D and innovation co-operations.
